KY-1016

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameKY-1016
Drug Alias NameKY-1016
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Bone morphogenetic protein 6
TargetsBone morphogenetic protein 6
Therapy Area/IndicationsAnemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKymab Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKymab Ltd
Inactive CompaniesN/A
Active IndicationsAnemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A